Depo-Provera Contraceptive Injection Prefilled Syringe 150 mg/mL Sterile Single-Use 1 mL (Rx)

Depo-Provera Contraceptive Injection Prefilled Syringe is a hormonal birth control method used to prevent pregnancy. Administered once every three months, it contains medroxyprogesterone acetate, a progestin that suppresses ovulation, thickens cervical mucus, and thins the uterine lining, thereby preventing fertilization and implantation. This long-acting reversible contraception is suitable for those seeking a convenient, reliable option without daily pill use. It may also be prescribed for menstrual regulation and to reduce endometriosis-related pain. Regular medical consultations are advised to monitor side effects.

Pfizer USPG presents Depo-Provera Contraceptive Injection, a trusted and highly effective method of birth control designed for today's busy lifestyle. Each sterile, single-use prefilled syringe delivers 150 mg/mL of medroxyprogesterone acetate, offering women a convenient, long-acting contraceptive option that requires administration only once every three months. With its proven track record, Depo-Provera allows women to take control of their reproductive health while enjoying the freedom of minimal maintenance.

Product Details and Features:

Active Ingredient: Each 1 mL syringe contains 150 mg of medroxyprogesterone acetate, a progestin that delivers reliable contraceptive effects.
Packaging: Available as a sterile, single-use prefilled syringe for easy administration, minimizing preparation time and complexity.
Indications: Specifically indicated for the prevention of pregnancy, Depo-Provera provides three months of contraception with a single injection.
Convenience: The quarterly injection schedule simplifies adherence, eliminating the need for daily contraceptive methods while maintaining effectiveness.
Established Efficacy: Backed by clinical studies and user satisfaction, Depo-Provera is a benchmark for injectable contraceptive options.

Mechanism of Action:

Depo-Provera works primarily via inhibition of gonadotropin release from the pituitary gland. This suppression halts the maturation of ovarian follicles and prevents ovulation. Additionally, medroxyprogesterone acetate induces changes in the cervical mucus, making it thicker and less permeable to sperm, and alters the endometrial lining, reducing the likelihood of implantation should fertilization occur.

Warnings:

• Bone Density: Long-term use may result in a reduction in bone mineral density, which might be reversible upon discontinuation. Consider evaluating bone health in users with prolonged exposure.
  
• Menstrual Changes: Users may experience alterations in menstrual bleeding patterns, ranging from irregular spotting to amenorrhea.
  
• Delayed Fertility Return: Fertility may be delayed following the cessation of injections, with an average return to ovulation of 10 months noted.
  
• Personal and Family Medical History: Evaluate any history of breast cancer, thromboembolic disorders, liver disease, or unexplained vaginal bleeding prior to use.

Side Effects:

Common side effects may include:

• Weight gain
  
• Headache
  
• Abdominal discomfort
  
• Mood swings or depression

Serious side effects, although rare, may include:

• Significant changes in vision or speech, potentially indicative of thromboembolic events
  
• Persistent or unusual abdominal pain
  
• Severe allergic reactions, such as rash, itching, or difficulty breathing

Conclusion:

Depo-Provera Contraceptive Injection by Pfizer USPG offers a secure and effective solution for women seeking long-term contraception with minimal daily maintenance. With its straightforward administration and established efficacy, it presents a favorable option for many women striving for reliable birth control. Always consult with a healthcare provider to ensure it aligns appropriately with individual health profiles and lifestyle preferences.